FDA and Drug Companies Face Off Over Diabetes Drugs' Link to Cancer
Certain Type-2 diabetes drugs may require further study into links with pancreatic cancer, the FDA has said.
Dangerous Drugs
Manufacturers Request New Jersey Tylenol Liver Damage Cases be Centralized
The makers of Tylenol have submitted an application to have NJ lawsuits alleging liver damage be centralized in one New Brunswick court.
First Actos Bladder Cancer Award Overturned
A California Judge has overturned the first class action award granted by a jury for a victim of Actor bladder cancer.
Australian Actos Victims Set To Join U.S. Class Action Lawsuit
Australian victims of the diabetes drug Actos, alleged to cause bladder cancer, may join in a U.S. lawsuit against the makers.
Pradaxa Litigation Update: Defendant to Hand Over Document
The federal judge presiding over the Pradaxa multidistrict litigation ordered the maker of the drug to turn over documents.
Another Blood Thinner Prompts Concerns Over Serious Injuries
Like Pradaxa, Xarelto, the latest blood thinner to be approved by the FDA, also faces fears over its allegedly serious and potentially fatal side effects.
SSRI Pregnancy Categories May Indicate Possible Risk to Fetus
Most SSRI drugs are classified into FDA Pregnancy Category C or D, indicating a possible risk to a fetus due to SSRI use in pregnancy.
More Lawsuits Filed for Zoloft Birth Defects
Pfizer currently faces 137 lawsuits alleging the company's popular antidepressant, Zoloft, is responsible for birth defects
Pradaxa Lawsuits Get Consolidated to One Court
The Judicial Panel on Multidistrict Litigation (JPML) will reportedly be consolidating all of the pending Pradaxa lawsuits to one federal court.
Whistleblower Lawsuit Filed Against Takeda Over Actos
A whistleblower suit filed against the maker of Actos alleges the company consistently downplayed heart failure cases linked to the drug.